|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net sales | |
| Cost of goods sold | |
| Gross profit | |
| Operating expense | |
| Selling, general and administrative expenses | |
| Amortization of intangible assets | |
| Other operating expenses | |
| Total operating expense | |
| Operating income | |
| Other expense | |
| Interest expense, net | |
| Other (expense) income, net | |
| Foreign exchange (loss) gain, net | |
| Total other expense | |
| Income before income taxes | |
| Provision for income taxes | |
| Net income | |
| Net loss attributable to noncontrolling interests | |
| Net income attributable to Medline Inc. | |
| Net loss per share attributable to Medline Inc. | |
| Basic (in dollars per share) | |
| Diluted (in dollars per share) | |
| Weighted average number of Class A common shares outstanding | |
| Basic (in shares) | |
| Diluted (in shares) | |
| Other comprehensive income (loss), net of tax | |
| Retirement plan, net of tax | |
| Net unrealized loss on derivative instruments | |
| Currency translation adjustment | |
| Total other comprehensive income (loss), net of tax | |
| Total comprehensive income | |
| Comprehensive loss attributable to noncontrolling interests | |
| Comprehensive income attributable to Medline Inc. |
Loading...